Lundbeckfonden Ventures takes fourth company public in six months
Another portfolio company of Lundbeckfonden Ventures has gone public and raised approximately USD 90 million in an IPO on the US Nasdaq. Fourth of the Danish ventures fund’s portfolio companies to go public since this summer.
BY MARTIN HAVTORN PETERSEN
Another portfolio company of Lundbeckfonden Ventures, the US-based biotech company ScPharmaceuticals, has carried out an IPO on Nasdaq in the US.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Lundbeck Foundation company succeeds in phase I
For abonnenter
Lundbeck Foundation company goes public
For abonnenter
